WO2009103553A3 - Bioäquivalenzdialyse - Google Patents

Bioäquivalenzdialyse Download PDF

Info

Publication number
WO2009103553A3
WO2009103553A3 PCT/EP2009/001233 EP2009001233W WO2009103553A3 WO 2009103553 A3 WO2009103553 A3 WO 2009103553A3 EP 2009001233 W EP2009001233 W EP 2009001233W WO 2009103553 A3 WO2009103553 A3 WO 2009103553A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
disorders
bioequivalence
dialysis
thrombocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/001233
Other languages
English (en)
French (fr)
Other versions
WO2009103553A2 (de
Inventor
Steffen Mitzner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Rostock
Original Assignee
Universitaet Rostock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Rostock filed Critical Universitaet Rostock
Priority to ES09712372T priority Critical patent/ES2391849T3/es
Priority to EP09712372A priority patent/EP2254619B8/de
Priority to US12/918,425 priority patent/US9265875B2/en
Publication of WO2009103553A2 publication Critical patent/WO2009103553A2/de
Publication of WO2009103553A3 publication Critical patent/WO2009103553A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • A61M1/3633—Blood component filters, e.g. leukocyte filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Behandlung von Blutkompositionsstörungen und Blutfunktionsstörungen. Dieses umfasst Schritte, bei denen man Blut oder Blutplasma eines Patienten extrakorporal mit einer zweiten Flüssigkeit (Bioäquivalent) in Kontakt bringt, wobei die zweite Flüssigkeit Blut oder modifiziertes Blut ist, welches mindestens Granulozyten, Thrombozyten und Erythrozyten umfasst. Die Erfindung betrifft ferner Vorrichtungen zur Durchführung dieses Verfahrens und die Verwendung einer solchen Vorrichtung oder von Blut oder modifiziertem Blut, welches Granulozyten, Thrombozyten und Erythrozyten umfasst, zur Behandlung von Blutkompositionsstörüngen und Blutfunktionsstörungen.
PCT/EP2009/001233 2008-02-22 2009-02-20 Bioäquivalenzdialyse Ceased WO2009103553A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09712372T ES2391849T3 (es) 2008-02-22 2009-02-20 Diálisis de bioquivalencia
EP09712372A EP2254619B8 (de) 2008-02-22 2009-02-20 Bioäquivalenzdialyse
US12/918,425 US9265875B2 (en) 2008-02-22 2009-02-20 Methods for treating blood composition and function disorders wherein a patient's blood plasma is extracorporeally contacted with donor blood or modified donor blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008010691A DE102008010691A1 (de) 2008-02-22 2008-02-22 Bioäquivalenzdialyse
DE102008010691.7 2008-02-22

Publications (2)

Publication Number Publication Date
WO2009103553A2 WO2009103553A2 (de) 2009-08-27
WO2009103553A3 true WO2009103553A3 (de) 2009-10-22

Family

ID=40896659

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/001233 Ceased WO2009103553A2 (de) 2008-02-22 2009-02-20 Bioäquivalenzdialyse

Country Status (5)

Country Link
US (1) US9265875B2 (de)
EP (1) EP2254619B8 (de)
DE (1) DE102008010691A1 (de)
ES (1) ES2391849T3 (de)
WO (1) WO2009103553A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008010691A1 (de) 2008-02-22 2009-08-27 Universität Rostock Bioäquivalenzdialyse
DE102013014751A1 (de) * 2013-09-06 2015-03-12 Fresenius Medical Care Deutschland Gmbh Verfahren zum Beeinflussen des Drucks innerhalb eines Heizbeutels während einer medizinischen Behandlung und medizinische Vorrichtung
CN104971391A (zh) * 2015-06-19 2015-10-14 南方医科大学珠江医院 新型组合型肝肾支持系统crrt模式管路
CN106310415A (zh) * 2016-09-27 2017-01-11 上海江夏血液技术有限公司 采用血细胞分离与血浆吸附技术的脑卒中治疗系统
JP2023522621A (ja) * 2020-04-14 2023-05-31 サイトソーベンツ・コーポレーション 免疫調整治療による免疫応答の改善と免疫麻痺の減少
EP4154925A1 (de) 2021-09-22 2023-03-29 Artcline GmbH Neuartige immunzellenbehandlung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051068A1 (de) * 2000-01-14 2001-07-19 Teraklin Aktiengesellschaft Verfahren und vorrichtung zur erhöhung und/oder verringerung der konzentration immunmodulatorisch wirksamer stoffe in stoffgemischen
WO2007046757A1 (en) * 2005-10-17 2007-04-26 Gambro Lundia Ab Extracorporeal blood cleaning

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970706053A (ko) * 1992-09-11 1997-11-03 더블유. 제랄드 뉴민 인공 간 장치 및 이의 사용방법(artificial liver apparatus and method)
DE19519065A1 (de) 1995-05-19 1996-11-21 Mitzner Steffen Verfahren und Einrichtung zur biologischen Elimination von unerwünschten lebenden und toten Partikeln aus biologischen und anderen empfindlichen Stoffgemischen
US5843474A (en) * 1995-10-11 1998-12-01 Reverse Transport Licensing & Consulting, Inc. Method of dialysis treatment, and dialysis apparatus related thereto
DE19627685C2 (de) 1996-07-10 2000-05-18 Fresenius Ag Verwendung einer Vorrichtung zum volumetrischen Bilanzieren von Flüssigkeiten
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
DE19831873A1 (de) * 1998-07-16 2000-03-30 Jens Altrichter Verfahren und Einrichtung zur therapeutischen Immunmodulation
US20030130194A1 (en) * 1998-07-16 2003-07-10 Jens Altrichter Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
DE19854338B4 (de) * 1998-11-25 2005-11-17 Ulrich Dr.med. Saueressig Verfahren und Einrichtung zur Nierenersatztherapie
DE19916352A1 (de) * 1999-04-12 2000-10-19 Braun Melsungen Ag Entfernung von hüllehaltigen Viren aus Blut, Plasma oder Serum
US20030129736A1 (en) * 1999-07-15 2003-07-10 Eduardo Mitrani Device and method for performing a biological modification of a fluid
EP1981963A1 (de) * 2004-12-27 2008-10-22 Fresenius Medical Care Deutschland GmbH Reaktor und reaktoreinheit mit hohlfasern
DE102005021305A1 (de) * 2005-05-09 2006-11-16 Fresenius Medical Care Deutschland Gmbh Reaktoreinheit und Reaktor mit einer derartigen Reaktoreinheit
DE102008010691A1 (de) 2008-02-22 2009-08-27 Universität Rostock Bioäquivalenzdialyse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051068A1 (de) * 2000-01-14 2001-07-19 Teraklin Aktiengesellschaft Verfahren und vorrichtung zur erhöhung und/oder verringerung der konzentration immunmodulatorisch wirksamer stoffe in stoffgemischen
WO2007046757A1 (en) * 2005-10-17 2007-04-26 Gambro Lundia Ab Extracorporeal blood cleaning

Also Published As

Publication number Publication date
US9265875B2 (en) 2016-02-23
ES2391849T3 (es) 2012-11-30
EP2254619B8 (de) 2012-07-11
DE102008010691A1 (de) 2009-08-27
EP2254619B1 (de) 2012-06-06
US20110042313A1 (en) 2011-02-24
WO2009103553A2 (de) 2009-08-27
EP2254619A2 (de) 2010-12-01

Similar Documents

Publication Publication Date Title
WO2008033978A3 (en) Method for using photoplethysmography to optimize fluid removal during renal replacement therapy by hemodialysis or hemofiltration
MX2010008591A (es) Dispositivos, sistemas y metodos de separacion de fluidos.
WO2008122048A3 (en) Removal of contrast agents from blood
WO2009135166A3 (en) Filamentary devices for treatment of vascular defects
WO2007120746A3 (en) Anti-clotting apparatus and methods for fluid handling system
WO2008005888A3 (en) Atherectomy devices and methods
WO2007137285A3 (en) Fluid access interface
PL1996253T3 (pl) Sposób co najmniej częściowego opróżniania pozaustrojowego obiegu krwi i urządzenie do hemodializy do realizacji sposobu
WO2010121750A8 (de) Verfahren zum entfernen von blut aus einem extrakorporalen blutkreislauf, behandlungsvorrichtung sowie schlauchsystem
SI2324871T1 (sl) Citratni antikoagulacijski sistem za zunajtelesne obdelave krvi
WO2009064984A3 (en) Dialysis systems and methods
WO2014058905A3 (en) Potassium-binding agents for treating hypertension and hyperkalemia
WO2009024947A3 (en) Device for dialysis and stimulation of a patient and method
WO2008067362A3 (en) Multiple lumen diffusion catheter
EP4585168A3 (de) Vorrichtung zur behandlung von aneurysmen
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2008058019A3 (en) Devices and methods for accessing and treating an aneurysm
WO2009146913A3 (de) Organizer zum lösbaren aufnehmen von komponenten von blutschlauchsätzen und verfahren zum herstellen sowie zum vorbereiten desselben
WO2009109351A3 (de) Vorrichtung und verfahren zur überwachung eines zugangs zu einem patienten, insbesondere eines gefässzugangs bei einer extrakorporalen blutbehandlung
WO2011133671A3 (en) Adsorption devices, systems and methods
WO2009098457A3 (en) Extracorporeal membrane oxygenation
WO2008127654A3 (en) Methods and compositions for intra-articular coagulation proteins
WO2013017240A3 (de) Verfahren zum entfernen von blut aus einem extrakorporalen blutkreislauf sowie vorrichtungen
WO2008118390A3 (en) Biomarkers for diagnostic and therapeutic methods
MX2015001508A (es) El uso de antitrombina en la oxigenacion por membrana extracorporea.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09712372

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009712372

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12918425

Country of ref document: US